BioHeart , Nasdaq: BHRT
A biotechnology company focused on using cells derived from a patient's body for treatment of heart damage.
Industry: Health Care
First Day Return: -4.8%
Industry: Health Care
| IPO Data | |
|---|---|
| IPO File Date | 02/13/2007 |
| Offer Price | $5.25 |
| Price Range $6.00 - $8.00 | |
| Offer Shares (mm) | 1.1 |
| Deal Size ($mm) | $6 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 02/18/2008 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $6 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Sunrise, FL, United States |
| Founded | 1999 |
| Employees at IPO | 22 |
| Website www.bioheartinc.com | |
BioHeart (BHRT) Performance
